메뉴 건너뛰기




Volumn 224, Issue , 2015, Pages 631-648

Apoa-i mimetics

Author keywords

ApoA I analogues; ApoA I infusion; ApoA I mimetics

Indexed keywords

4F; 5A PHOSPHOLIPID COMPLEX; ABC TRANSPORTER A1; ABC TRANSPORTER G1; APOLIPOPROTEIN A1; APOLIPOPROTEIN A1 MIMETIC AGENT; APOLIPOPROTEIN B; ATI 5261; CER 001; CSL 111; ETC 216; ETC 642; FX 5A; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; L 6F; LOW DENSITY LIPOPROTEIN RECEPTOR; PEPTIDOMIMETIC AGENT; PLACEBO; REACTIVE OXYGEN METABOLITE; TRIPA 1; UNCLASSIFIED DRUG; ANTILIPEMIC AGENT; APOA1 PROTEIN, HUMAN; PEPTIDE FRAGMENT;

EID: 84919682813     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-319-09665-0_21     Document Type: Conference Paper
Times cited : (35)

References (65)
  • 2
    • 0027994776 scopus 로고
    • Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits
    • Ameli S, Hultgardh-Nilsson A, Cercek B, Shah PK, Forrester JS, Ageland H, Nilsson J (1994) Recombinant apolipoprotein A-I Milano reduces intimal thickening after balloon injury in hypercholesterolemic rabbits. Circulation 90:1935–1941.
    • (1994) Circulation , vol.90 , pp. 1935-1941
    • Ameli, S.1    Hultgardh-Nilsson, A.2    Cercek, B.3    Shah, P.K.4    Forrester, J.S.5    Ageland, H.6    Nilsson, J.7
  • 4
    • 0024550898 scopus 로고
    • High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits
    • Badimon JJ, Badimon L, Galvez A, Dische R, Fuster V (1989) High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits. Lab Invest 60:455–461.
    • (1989) Lab Invest , vol.60 , pp. 455-461
    • Badimon, J.J.1    Badimon, L.2    Galvez, A.3    Dische, R.4    Fuster, V.5
  • 5
    • 0025322265 scopus 로고
    • Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit
    • Badimon JJ, Badimon L, Fuster V (1990) Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit. J Clin Invest 85:1234–1241. doi:10.1172/jci114558.
    • (1990) J Clin Invest , vol.85 , pp. 1234-1241
    • Badimon, J.J.1    Badimon, L.2    Fuster, V.3
  • 6
    • 78449281377 scopus 로고    scopus 로고
    • Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials
    • Baigent C, Blackwell L, Emberson J, Holland LE, Reith C, Bhala N, Peto R, Barnes EH, Keech A, Simes J, Collins R (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376:1670–1681. doi:10.1016/s0140-6736(10)61350-5.
    • (2010) Lancet , vol.376 , pp. 1670-1681
    • Baigent, C.1    Blackwell, L.2    Emberson, J.3    Holland, L.E.4    Reith, C.5    Bhala, N.6    Peto, R.7    Barnes, E.H.8    Keech, A.9    Simes, J.10    Collins, R.11
  • 9
    • 77952737056 scopus 로고    scopus 로고
    • A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice
    • Bielicki JK, Zhang H, Cortez Y, Zheng Y, Narayanaswami V, Patel A, Johansson J, Azhar S (2010) A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice. J Lipid Res 51:1496–1503. doi:10.1194/ jlr.M003665.
    • (2010) J Lipid Res , vol.51 , pp. 1496-1503
    • Bielicki, J.K.1    Zhang, H.2    Cortez, Y.3    Zheng, Y.4    Narayanaswami, V.5    Patel, A.6    Johansson, J.7    Azhar, S.8
  • 14
    • 44449103671 scopus 로고    scopus 로고
    • Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches
    • De Goma EM, deGoma RL, Rader DJ (2008) Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches. J Am Coll Cardiol 51:2199–2211. doi:10.1016/j.jacc.2008.03.016.
    • (2008) J am Coll Cardiol , vol.51 , pp. 2199-2211
    • De Goma, E.M.1    Degoma, R.L.2    Rader, D.J.3
  • 15
    • 79960699071 scopus 로고    scopus 로고
    • The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins
    • Di Bartolo BA, Nicholls SJ, Bao S, Rye KA, Heather AK, Barter PJ, Bursill C (2011a) The apolipoprotein A-I mimetic peptide ETC-642 exhibits anti-inflammatory properties that are comparable to high density lipoproteins. Atherosclerosis 217:395–400. doi:10.1016/j.athero sclerosis.2011.04.001.
    • (2011) Atherosclerosis , vol.217 , pp. 395-400
    • Di Bartolo, B.A.1    Nicholls, S.J.2    Bao, S.3    Rye, K.A.4    Heather, A.K.5    Barter, P.J.6    Bursill, C.7
  • 16
    • 82255173770 scopus 로고    scopus 로고
    • The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit
    • Di Bartolo BA, Vanags LZ, Tan JT, Bao S, Rye KA, Barter PJ, Bursill CA (2011b) The apolipoprotein A-I mimetic peptide, ETC-642, reduces chronic vascular inflammation in the rabbit. Lipids Health Dis 10:224. doi:10.1186/1476-511x-10-224.
    • (2011) Lipids Health Dis , vol.10 , pp. 224
    • Di Bartolo, B.A.1    Vanags, L.Z.2    Tan, J.T.3    Bao, S.4    Rye, K.A.5    Barter, P.J.6    Bursill, C.A.7
  • 17
    • 77955173940 scopus 로고    scopus 로고
    • Structure/function relationships of apolipoprotein a-I mimetic peptides: Implications for antiatherogenic activities of high-density lipoprotein
    • D’Souza W, Stonik JA, Murphy A, Demosky SJ, Sethi AA, Moore XL, Chin-Dusting J, Remaley AT, Sviridov D (2010) Structure/function relationships of apolipoprotein a-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein. Circ Res 107:217–227. doi:10.1161/circresaha.110.216507.
    • (2010) Circ Res , vol.107 , pp. 217-227
    • D’Souza, W.1    Stonik, J.A.2    Murphy, A.3    Demosky, S.J.4    Sethi, A.A.5    Moore, X.L.6    Chin-Dusting, J.7    Remaley, A.T.8    Sviridov, D.9
  • 20
    • 0028887870 scopus 로고
    • Molecular physiology of reverse cholesterol transport
    • Fielding CJ, Fielding PE (1995) Molecular physiology of reverse cholesterol transport. J Lipid Res 36:211–228.
    • (1995) J Lipid Res , vol.36 , pp. 211-228
    • Fielding, C.J.1    Fielding, P.E.2
  • 21
    • 0019226420 scopus 로고
    • A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family
    • Franceschini G, Sirtori CR, Capurso A 2nd, Weisgraber KH, Mahley RW (1980) A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family. J Clin Invest 66:892–900. doi:10.1172/jci109956.
    • (1980) J Clin Invest , vol.66 , pp. 892-900
    • Franceschini, G.1    Sirtori, C.R.2    Capurso, A.3    Weisgraber, K.H.4    Mahley, R.W.5
  • 24
    • 0017384270 scopus 로고
    • High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study
    • Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707–714.
    • (1977) Am J Med , vol.62 , pp. 707-714
    • Gordon, T.1    Castelli, W.P.2    Hjortland, M.C.3    Kannel, W.B.4    Dawber, T.R.5
  • 30
    • 80053261614 scopus 로고    scopus 로고
    • Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits
    • Iwata A, Miura S, Zhang B, Imaizumi S, Uehara Y, Shiomi M, Saku K (2011) Antiatherogenic effects of newly developed apolipoprotein A-I mimetic peptide/phospholipid complexes against aortic plaque burden in Watanabe-heritable hyperlipidemic rabbits. Atherosclerosis 218:300–307. doi:10.1016/j.atherosclerosis.2011.05.029.
    • (2011) Atherosclerosis , vol.218 , pp. 300-307
    • Iwata, A.1    Miura, S.2    Zhang, B.3    Imaizumi, S.4    Uehara, Y.5    Shiomi, M.6    Saku, K.7
  • 31
    • 78751640788 scopus 로고    scopus 로고
    • Meta-analysis: Statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk
    • Jafri H, Alsheikh-Ali AA, Karas RH (2010) Meta-analysis: statin therapy does not alter the association between low levels of high-density lipoprotein cholesterol and increased cardiovascular risk. Ann Intern Med 153:800–808. doi:10.7326/0003-4819-153-12-201012210-00006.
    • (2010) Ann Intern Med , vol.153 , pp. 800-808
    • Jafri, H.1    Alsheikh-Ali, A.A.2    Karas, R.H.3
  • 33
    • 33748681287 scopus 로고    scopus 로고
    • Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
    • Kontush A, Chapman MJ (2006) Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58:342–374. doi:10.1124/pr.58.3.1.
    • (2006) Pharmacol Rev , vol.58 , pp. 342-374
    • Kontush, A.1    Chapman, M.J.2
  • 34
    • 84888302969 scopus 로고    scopus 로고
    • Reconstituted HDL for the acute treatment of acute coronary syndrome
    • Krause BR, Remaley AT (2013) Reconstituted HDL for the acute treatment of acute coronary syndrome. Curr Opin Lipidol 24:480–486. doi:10.1097/mol.0000000000000020.
    • (2013) Curr Opin Lipidol , vol.24 , pp. 480-486
    • Krause, B.R.1    Remaley, A.T.2
  • 35
    • 33745369351 scopus 로고    scopus 로고
    • Endothelial and antithrombotic actions of HDL
    • Mineo C, Deguchi H, Griffin JH, Shaul PW (2006) Endothelial and antithrombotic actions of HDL. Circ Res 98:1352–1364. doi:10.1161/01.res.0000225982.01988.93.
    • (2006) Circ Res , vol.98 , pp. 1352-1364
    • Mineo, C.1    Deguchi, H.2    Griffin, J.H.3    Shaul, P.W.4
  • 38
    • 0037154287 scopus 로고    scopus 로고
    • Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol
    • Navab M, Anantharamaiah GM, Hama S, Garber DW, Chaddha M, Hough G, Lallone R, Fogelman AM (2002) Oral administration of an Apo A-I mimetic Peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol. Circulation 105:290–292.
    • (2002) Circulation , vol.105 , pp. 290-292
    • Navab, M.1    Anantharamaiah, G.M.2    Hama, S.3    Garber, D.W.4    Chaddha, M.5    Hough, G.6    Lallone, R.7    Fogelman, A.M.8
  • 39
    • 4544383898 scopus 로고    scopus 로고
    • Oral D-4F causes formation of pre-beta highdensity lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice
    • Navab M, Anantharamaiah GM, Reddy ST, Hama S, Hough G, Grijalva VR, Wagner AC, Frank JS, Datta G, Garber D, Fogelman AM (2004) Oral D-4F causes formation of pre-beta highdensity lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice. Circulation 109:3215–3220. doi:10.1161/01.cir.0000134275.90823.87.
    • (2004) Circulation , vol.109 , pp. 3215-3220
    • Navab, M.1    Anantharamaiah, G.M.2    Reddy, S.T.3    Hama, S.4    Hough, G.5    Grijalva, V.R.6    Wagner, A.C.7    Frank, J.S.8    Datta, G.9    Garber, D.10    Fogelman, A.M.11
  • 41
    • 32044448047 scopus 로고    scopus 로고
    • Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano
    • Nicholls SJ, Tuzcu EM, Sipahi I, Schoenhagen P, Crowe T, Kapadia S, Nissen SE (2006) Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano. J Am Coll Cardiol 47:992–997. doi:10.1016/j.jacc.2005.11.040.
    • (2006) J am Coll Cardiol , vol.47 , pp. 992-997
    • Nicholls, S.J.1    Tuzcu, E.M.2    Sipahi, I.3    Schoenhagen, P.4    Crowe, T.5    Kapadia, S.6    Nissen, S.E.7
  • 43
    • 80355132735 scopus 로고    scopus 로고
    • Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: Cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells
    • Ohnsorg PM, Mary JL, Rohrer L, Pech M, Fingerle J, von Eckardstein A (2011) Trimerized apolipoprotein A-I (TripA) forms lipoproteins, activates lecithin: cholesterol acyltransferase, elicits lipid efflux, and is transported through aortic endothelial cells. Biochim Biophys Acta 1811:1115–1123. doi:10.1016/j.bbalip.2011.09.001.
    • (2011) Biochim Biophys Acta , vol.1811 , pp. 1115-1123
    • Ohnsorg, P.M.1    Mary, J.L.2    Rohrer, L.3    Pech, M.4    Fingerle, J.5    Von Eckardstein, A.6
  • 44
    • 63849154779 scopus 로고    scopus 로고
    • Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice
    • Pedersen TX, Bro S, Andersen MH, Etzerodt M, Jauhiainen M, Moestrup S, Nielsen LB (2009) Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice. Atherosclerosis 202:372–381. doi:10.1016/j.atherosclerosis.2008.04.041.
    • (2009) Atherosclerosis , vol.202 , pp. 372-381
    • Pedersen, T.X.1    Bro, S.2    Ersen, M.H.3    Etzerodt, M.4    Jauhiainen, M.5    Moestrup, S.6    Nielsen, L.B.7
  • 47
    • 0025902231 scopus 로고
    • Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI
    • Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM (1991) Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 353:265–267. doi:10.1038/353265a0.
    • (1991) Nature , vol.353 , pp. 265-267
    • Rubin, E.M.1    Krauss, R.M.2    Spangler, E.A.3    Verstuyft, J.G.4    Clift, S.M.5
  • 48
    • 78649512581 scopus 로고    scopus 로고
    • Nanobiotechnology applications of reconstituted high density lipoprotein
    • Ryan RO (2010) Nanobiotechnology applications of reconstituted high density lipoprotein. J Nanobiotechnol 8:28. doi:10.1186/1477-3155-8-28.
    • (2010) J Nanobiotechnol , vol.8 , pp. 28
    • Ryan, R.O.1
  • 50
    • 57749116008 scopus 로고    scopus 로고
    • Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides
    • Sethi AA, Stonik JA, Thomas F, Demosky SJ, Amar M, Neufeld E, Brewer HB, Davidson WS, D’Souza W, Sviridov D, Remaley AT (2008) Asymmetry in the lipid affinity of bihelical amphipathic peptides. A structural determinant for the specificity of ABCA1-dependent cholesterol efflux by peptides. J Biol Chem 283:32273–32282. doi:10.1074/jbc.M804461200.
    • (2008) J Biol Chem , vol.283 , pp. 32273-32282
    • Sethi, A.A.1    Stonik, J.A.2    Thomas, F.3    Demosky, S.J.4    Amar, M.5    Neufeld, E.6    Brewer, H.B.7    Davidson, W.S.8    D’Souza, W.9    Sviridov, D.10    Remaley, A.T.11
  • 52
    • 0035954267 scopus 로고    scopus 로고
    • High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization
    • Shah PK, Yano J, Reyes O, Chyu KY, Kaul S, Bisgaier CL, Drake S, Cercek B (2001) High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization. Circulation 103:3047–3050.
    • (2001) Circulation , vol.103 , pp. 3047-3050
    • Shah, P.K.1    Yano, J.2    Reyes, O.3    Chyu, K.Y.4    Kaul, S.5    Bisgaier, C.L.6    Drake, S.7    Cercek, B.8
  • 53
    • 0028985103 scopus 로고
    • Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits
    • Soma MR, Donetti E, Parolini C, Sirtori CR, Fumagalli R, Franceschini G (1995) Recombinant apolipoprotein A-IMilano dimer inhibits carotid intimal thickening induced by perivascular manipulation in rabbits. Circ Res 76:405–411.
    • (1995) Circ Res , vol.76 , pp. 405-411
    • Soma, M.R.1    Donetti, E.2    Parolini, C.3    Sirtori, C.R.4    Fumagalli, R.5    Franceschini, G.6
  • 54
    • 84891098065 scopus 로고    scopus 로고
    • Biological nanoparticles and their influence on organisms
    • Stanley S (2014) Biological nanoparticles and their influence on organisms. Curr Opin Biotechnol 28:69–74. doi:10.1016/j.copbio.2013.11.014.
    • (2014) Curr Opin Biotechnol , vol.28 , pp. 69-74
    • Stanley, S.1
  • 60
    • 0031910099 scopus 로고    scopus 로고
    • ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice
    • Voyiaziakis E, Goldberg IJ, Plump AS, Rubin EM, Breslow JL, Huang LS (1998) ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice. J Lipid Res 39:313–321.
    • (1998) J Lipid Res , vol.39 , pp. 313-321
    • Voyiaziakis, E.1    Goldberg, I.J.2    Plump, A.S.3    Rubin, E.M.4    Breslow, J.L.5    Huang, L.S.6
  • 63
    • 48549096875 scopus 로고    scopus 로고
    • Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties
    • Wool GD, Reardon CA, Getz GS (2008) Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties. J Lipid Res 49:1268–1283. doi:10.1194/jlr.M700552-JLR200.
    • (2008) J Lipid Res , vol.49 , pp. 1268-1283
    • Wool, G.D.1    Reardon, C.A.2    Getz, G.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.